Aruna Bio, Inc. is a privately funded biotechnology company focused on the development of neural exosomes for the treatment of neurodegenerative diseases. The company utilizes it's proprietary neural exosomes both as a therapeutic to treat neurodegenerative diseases but also as a delivery vehicle for a range of payloads including siRNAs and antibodies where delivery to the brain and CNS is important.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Georgia
Company HQ Country:
United States
Year Founded:
2002
Main Therapeutic Focus:
CNS/Neurological
Lead Product in Development:
AB126 neural exosome
Development Phase of Primary Product:
Pre-Clinical
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided
Speaker
